1. Leukemia. 2016 Jun;30(6):1422-5. doi: 10.1038/leu.2015.320. Epub 2015 Nov 20.

Quizartinib elicits differential responses that correlate with karyotype and 
genotype of the leukemic clone.

Nybakken GE(1), Canaani J(2), Roy D(3), Morrissette JD(4), Watt CD(4), Shah 
NP(5), Smith CC(5), Bagg A(4), Carroll M(2)(6), Perl AE(2).

Author information:
(1)Department of Pathology, Kaiser Permanente Santa Clara, CA, USA.
(2)Division of Hematology and Oncology, University of Pennsylvania, 
Philadelphia, PA, USA.
(3)Department of Pathology, Rowan University, Glassboro, NJ, USA.
(4)Department of Pathology and Laboratory Medicine, University of Pennsylvania, 
Philadelphia, PA, USA.
(5)Department of Medicine, Division of Hematology/Oncology, University of 
California, San Francisco, San Francisco, CA, USA.
(6)Philadelphia Veterans Hospital, Philadelphia, PA, USA.

DOI: 10.1038/leu.2015.320
PMCID: PMC4927337
PMID: 26585411 [Indexed for MEDLINE]

Conflict of interest statement: CONFLICT OF INTEREST AEP has served as a 
consultant to Ambit Biosciences, Astellas Pharmaceuticals and Arog 
Pharmaceuticals. CCS received clinical trial grant funding from Astellas. The 
remaining authors declare no conflict of interest.